UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adipokines Deregulate Cellular Communication via Epigenetic Repression of Gap Junction Loci in Obese Endometrial Cancer

Cancer research (Chicago, Ill.), 2019-01, Vol.79 (1), p.196-208

2019

Volltextzugriff (PDF)

Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle-Related Transcription and Attenuated Androgen Response

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4), p.853-864

2018

Volltextzugriff (PDF)

NOTCH Signaling via WNT Regulates the Proliferation of Alternative, CCR2-Independent Tumor-Associated Macrophages in Hepatocellular Carcinoma

Cancer research (Chicago, Ill.), 2019-08, Vol.79 (16), p.4160-4172

2019

Volltextzugriff (PDF)

Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate Cancer

Cancer research (Chicago, Ill.), 2021-08, Vol.81 (15), p.4110-4123

2021

Volltextzugriff (PDF)

Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD

Cancer research (Chicago, Ill.), 2021-06, Vol.81 (12), p.3270-3282

2021

Volltextzugriff (PDF)

Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer

Cancer research (Chicago, Ill.), 2020-04, Vol.80 (7), p.1551-1563

2020

Volltextzugriff (PDF)

Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth

Cancer research (Chicago, Ill.), 2005-03, Vol.65 (6), p.2287-2295

2005

Volltextzugriff (PDF)

The Cancer Editome Atlas: A Resource for Exploratory Analysis of the Adenosine-to-Inosine RNA Editome in Cancer

Cancer research (Chicago, Ill.), 2019-06, Vol.79 (11), p.3001-3006

2019

Volltextzugriff (PDF)

Abstract 2939: Developing new therapeutic strategy to bladder cancer by targeting CK1 delta

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2939-2939

2019

Volltextzugriff (PDF)

Abstract 2766: Amplification-associated upregulation of genes involved in oxidative phosphorylation for disseminated prostate cancer cells

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2766-2766

2019

Volltextzugriff (PDF)

Abstract 173: Upregulated EPHB2 and SRC pathways modulate spatial EGFR dynamics and malignant phenotypes and predict poor prognosis in prostate cancer

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.173-173

2019

Volltextzugriff (PDF)

Abstract 6284: Multimoics reveal aberrant pathways and regulation of castration resistant and metastatic prostate cancer

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.6284-6284

2024

Volltextzugriff (PDF)

Abstract 4569: Digitizing single-cell expression patterns in urine for prostate cancer detection

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4569-4569

2014

Volltextzugriff (PDF)

Abstract 3402: Castration resistance transcriptome in prostate cancer revealed by single-cell RNA-seq

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3402-3402

2018

Volltextzugriff (PDF)

Abstract 4197: Interaction of B lymphoma cells with the microenvironment affects ibrutinib sensitivity

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4197-4197

2017

Volltextzugriff (PDF)

The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers

Cancer research (Chicago, Ill.), 1998-08, Vol.58 (16), p.3677-3683

1998

Volltextzugriff (PDF)

Abstract 2530: Optimization of 5,6-fused pyrimidine-based kinase inhibitors by computer-aided drug design for the treatment of AML

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2530-2530

2014

Volltextzugriff (PDF)

Abstract 4494: MPT0G066, a novel microtubule-destabilizing agent, induces cell apoptosis and potentiates antineoplastic effects of cisplatin in human ovarian cancer cells in vitro and in vivo

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.4494-4494

2013

Volltextzugriff (PDF)

Abstract PO4-05-10: A Carryover Effect: Antibody Drug Conjugates Constantly Provide a Substantial Improvement in Overall Survival more than in Progression-free Survival

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO4-05-10-PO4-05-10

2024

Volltextzugriff (PDF)

Abstract P2-10-09: Oxysterol profiling in breast adipose tissue identifies brassicasterol and 24-hydroxycholesterol as breast cancer risk predictors

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-10-09

2022

Volltextzugriff (PDF)

Abstract CT028: A pilot study of pembrolizumab and exemestane/leuprolide in premenopausal hormone receptor positive/HER2 negative locally advanced or metastatic breast cancer (PEER)

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.CT028-CT028

2021

Volltextzugriff (PDF)

Abstract 454: Glucocorticoids enhance metastatsis and tumorigenicity in a triple negative breast cancer cell line

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.454-454

2012

Volltextzugriff (PDF)

Abstract 1970: Melatonin inhibits osteolytic bone metastasis through interrupting cancer cells-derived osteolytic factor and reduce osteoclast differentiation

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.1970-1970

2019

Volltextzugriff (PDF)

Abstract 4007: Decipher the myth between progression-free survival and overall survival in HER-2 positive metastatic nreast cancer: Anti-HER2 antibody as the constant winner—A hypothesis-driven meta-regression analysis

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.4007-4007

2019

Volltextzugriff (PDF)

Abstract P4-01-34: Benefits Provided by Antibody Drug Conjugates in Overall Survival Outweighs those in Progression-free Survival for Metastatic Breast Cancer: A Class Effect

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.P4-P4-01-34

2023

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(37)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Kollektion

Menü

Weitere Dienste

Einstellungen

Adipokines Deregulate Cellular Communication via Epigenetic Repression of Gap Junction Loci in Obese Endometrial Cancer

Single-Cell RNA-seq Reveals a Subpopulation of Prostate Cancer Cells with Enhanced Cell-Cycle-Related Transcription and Attenuated Androgen Response

NOTCH Signaling via WNT Regulates the Proliferation of Alternative, CCR2-Independent Tumor-Associated Macrophages in Hepatocellular Carcinoma

Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate Cancer

Afatinib Exerts Immunomodulatory Effects by Targeting the Pyrimidine Biosynthesis Enzyme CAD

Single-Cell Proteomic Profiling Identifies Combined AXL and JAK1 Inhibition as a Novel Therapeutic Strategy for Lung Cancer

Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth

The Cancer Editome Atlas: A Resource for Exploratory Analysis of the Adenosine-to-Inosine RNA Editome in Cancer

Abstract 2939: Developing new therapeutic strategy to bladder cancer by targeting CK1 delta

Abstract 2766: Amplification-associated upregulation of genes involved in oxidative phosphorylation for disseminated prostate cancer cells

Abstract 173: Upregulated EPHB2 and SRC pathways modulate spatial EGFR dynamics and malignant phenotypes and predict poor prognosis in prostate cancer

Abstract 6284: Multimoics reveal aberrant pathways and regulation of castration resistant and metastatic prostate cancer

Abstract 4569: Digitizing single-cell expression patterns in urine for prostate cancer detection

Abstract 3402: Castration resistance transcriptome in prostate cancer revealed by single-cell RNA-seq

Abstract 4197: Interaction of B lymphoma cells with the microenvironment affects ibrutinib sensitivity

The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers

Abstract 2530: Optimization of 5,6-fused pyrimidine-based kinase inhibitors by computer-aided drug design for the treatment of AML

Abstract 4494: MPT0G066, a novel microtubule-destabilizing agent, induces cell apoptosis and potentiates antineoplastic effects of cisplatin in human ovarian cancer cells in vitro and in vivo

Abstract PO4-05-10: A Carryover Effect: Antibody Drug Conjugates Constantly Provide a Substantial Improvement in Overall Survival more than in Progression-free Survival

Abstract P2-10-09: Oxysterol profiling in breast adipose tissue identifies brassicasterol and 24-hydroxycholesterol as breast cancer risk predictors

Abstract CT028: A pilot study of pembrolizumab and exemestane/leuprolide in premenopausal hormone receptor positive/HER2 negative locally advanced or metastatic breast cancer (PEER)

Abstract 454: Glucocorticoids enhance metastatsis and tumorigenicity in a triple negative breast cancer cell line

Abstract 1970: Melatonin inhibits osteolytic bone metastasis through interrupting cancer cells-derived osteolytic factor and reduce osteoclast differentiation

Abstract 4007: Decipher the myth between progression-free survival and overall survival in HER-2 positive metastatic nreast cancer: Anti-HER2 antibody as the constant winner—A hypothesis-driven meta-regression analysis

Abstract P4-01-34: Benefits Provided by Antibody Drug Conjugates in Overall Survival Outweighs those in Progression-free Survival for Metastatic Breast Cancer: A Class Effect

Aktive Filter

Suchergebnisse filtern